Poor Agreement between Clinician Response Ratings and Calculated Response Measures in Patients with Chronic Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 11, 2012, Pages 1649-1655

  Palmer, Jeanne M ^a   Lee, Stephanie J ^b   Chai, Xiaoyu ^b   Storer, Barry E ^b   Flowers, Mary E D ^b   Schultz, Kirk R ^c   Inamoto, Yoshihiro ^b   Cutler, Corey ^d   Pidala, Joseph ^e   Arora, Mukta ^f   Jacobsohn, David A ^g   Carpenter, Paul A ^b   Pavletic, Steven Z ^h   Martin, Paul J ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Allogeneic hematopoietic cell transplantation; Chronic graft versus host disease; Response assessment

Indexed keywords

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; EYE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH; OUTCOME ASSESSMENT; PRESCHOOL CHILD; SCHOOL CHILD; SKIN;

ADOLESCENT; ADULT; AGED; ALGORITHMS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; ORGAN SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84867539234     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.05.005     Document Type: Article

References (21)

1. Lee S.J., Vogelsang G., Flowers M.E. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003, 9:215-233.
2. Shulman H., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
3. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
4. Pidala J., Kurland B., Chai X., et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood 2011, 117:4651-4657.
5. Arai S., Jagasia M., Storer B., et al. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood 2011, 118:4242-4249.
6. Arora M., Wagner J.E., Davies S.M., et al. Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease. Biol Blood Marrow Transplant 2001, 7:265-273.
7. Busca A., Locatelli F., Marmont F., Audisio E., Falda M. Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease. Haematologica 2003, 88:837-839.
8. Chen G.L., Arai S., Flowers M.E., et al. A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies. Blood 2011, 118:4070-4078.
9. Couriel D.R., Saliba R., Escalón M.P., et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol 2005, 130:409-417.
10. Couriel D.R., Hosing C., Saliba R., et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006, 107:3074-3080.
11. Cutler C., Miklos D., Kim H.T., et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 2006, 108:756-762.
12. Jacobsohn D.A., Chen A.R., Zahurak M., et al. Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. J Clin Oncol 2007, 25:4255-4261.
13. Flowers M.E., Apperley J.F., van Besien K., et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008, 112:2667-2674.
14. Pavletic S.Z., Martin P., Lee S.J., et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006, 12:252-266.
15. Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD. Biol Blood Marrow Transplant 2011, 17:1114-1120. Chronic GVHD Consortium.
16. Mitchell S.A., Jacobsohn D., Thormann Powers K.E., et al. A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. Biol Blood Marrow Transplant 2011, 17:1619-1629.
17. Fleiss J.L., Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educational and Psychological Measurement 1973, 613-619. Sage Publications, Thousand Oaks, CA.
18. Jacobsohn D.A., Rademaker A., Kaup M., Vogelsang G.B. Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD. Bone Marrow Transplant 2009, 44:813-819.
19. Inamoto Y., Chai X., Kurland B.F., et al. Validation of measurement scales in ocular graft-versus-host disease. Ophthalmology 2012, 119:487-493.
20. Pidala J., Vogelsang G., Martin P., et al. Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study. Haematologica 2012, 97:451-458.
21. Carpenter P.A. How I conduct a comprehensive chronic graft-versus-host disease assessment. Blood 2011, 118:2679-2687.